BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 29393370)

  • 21. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
    Xu B
    Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
    Yang A; Wang X; Hu Y; Shang C; Hong Y
    Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
    Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
    DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
    Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
    Front Genet; 2019; 10():419. PubMed ID: 31130992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray.
    Wang L; Wei B; Hu G; Wang L; Bi M; Sun Z; Jin Y
    Mol Med Rep; 2015 Aug; 12(2):1991-6. PubMed ID: 25901754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
    Wei B; Wang L; Zhao J
    Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Potential Prognostic Gene Signature for Predicting Survival for Glioblastoma Patients.
    Hou Z; Yang J; Wang H; Liu D; Zhang H
    Biomed Res Int; 2019; 2019():9506461. PubMed ID: 31032367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 6‑gene risk score system constructed for predicting the clinical prognosis of pancreatic adenocarcinoma patients.
    Liu Y; Zhu D; Xing H; Hou Y; Sun Y
    Oncol Rep; 2019 Mar; 41(3):1521-1530. PubMed ID: 30747226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
    Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
    Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
    Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
    Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel methylation signature predicts radiotherapy sensitivity in glioma.
    Feng Y; Li G; Shi Z; Yan X; Wang Z; Jiang H; Chen Y; Li R; Zhai Y; Chang Y; Zhang W; Yuan F
    Sci Rep; 2020 Nov; 10(1):20406. PubMed ID: 33230136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 4-gene panel predicting the survival of patients with glioblastoma.
    Guo XX; Su J; He XF
    J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
    Lei CG; Jia XY; Sun WJ
    Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.